These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Levels of uroporphyrinogen decarboxylase (URO-D) in erythrocytes of Italian porphyria cutanea tarda patients. Tavazzi D; Martinez di Montemuros F; Fargion S; Fracanzani AL; Fiorelli G; Cappellini MD Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):27-32. PubMed ID: 11929044 [TBL] [Abstract][Full Text] [Related]
24. Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients. Held JL; Sassa S; Kappas A; Harber LC J Invest Dermatol; 1989 Sep; 93(3):332-4. PubMed ID: 2768832 [TBL] [Abstract][Full Text] [Related]
25. Fecal coproporphyrin isomers in sporadic and familial porphyria cutanea tarda. Badcock NR; Szep DA; Zoanetti GD; Lewis BD Clin Chem; 1995 Sep; 41(9):1315-7. PubMed ID: 7656445 [No Abstract] [Full Text] [Related]
26. Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives. Badenas C; To-Figueras J; Phillips JD; Warby CA; Muñoz C; Herrero C Clin Genet; 2009 Apr; 75(4):346-53. PubMed ID: 19419417 [TBL] [Abstract][Full Text] [Related]
27. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity. Kushner JP; Barbuto AJ; Lee GR J Clin Invest; 1976 Nov; 58(5):1089-97. PubMed ID: 993332 [TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of familial porphyria cutanea tarda. Roberts AG; Elder GH; Newcombe RG; Enriquez de Salamanca R; Munoz JJ J Med Genet; 1988 Oct; 25(10):669-76. PubMed ID: 3225822 [TBL] [Abstract][Full Text] [Related]
33. Haem biosynthesis and human porphyria cutanea tarda: effects of alcohol intake. Mukerji SK Indian J Exp Biol; 2000 Jul; 38(7):635-42. PubMed ID: 11215304 [TBL] [Abstract][Full Text] [Related]
34. The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population. Méndez M; Rossetti MV; Del C Batlle AM; Parera VE J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):417-24. PubMed ID: 15761419 [TBL] [Abstract][Full Text] [Related]
35. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection. Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661 [TBL] [Abstract][Full Text] [Related]
36. Three new mutations in the uroporphyrinogen decarboxylase gene in familial porphyria cutanea tarda. Mutation in brief no. 237. Online. McManus JF; Begley CG; Sassa S; Ratnaike S Hum Mutat; 1999; 13(5):412. PubMed ID: 10338097 [TBL] [Abstract][Full Text] [Related]
38. A case of porphyria cutanea tarda in the setting of hepatitis C infection and tobacco usage. Lederhandler M; Chen L; Meehan SA; Brinster NK; Neimann A Dermatol Online J; 2019 Dec; 25(12):. PubMed ID: 32045169 [TBL] [Abstract][Full Text] [Related]
39. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). Karlsson C; Hansson L; Celsing F; Lundin J Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854 [TBL] [Abstract][Full Text] [Related]
40. Erythrocyte uroporphyrinogen decarboxylase activity in 80 unrelated patients with porphyria cutanea tarda. Kószó F; Morvay M; Dobozy A; Simon N Br J Dermatol; 1992 May; 126(5):446-9. PubMed ID: 1610684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]